Friedl, Andrew
Abstract
**Background:** Lactate and pyruvate are often described as exercise metabolites, mitochondrial fuels, and signaling molecules. Recent skeletal-muscle studies make that description more precise but also narrower: transporter context, substrate abundance, and training state determine whether the observed endpoint is TCA-cycle routing, mitochondrial biogenesis, epigenomic remodeling, or whole-performance change.
**Objective:** This working paper defines an evidence-bounded lactate-pyruvate routing model for skeletal-muscle mitochondrial adaptation and separates fuel-signaling claims from exercise-performance or treatment claims.
**Methods:** PubMed and PubMed Central were searched on 2026-10-05 for primary studies linking lactate, pyruvate, monocarboxylate transporters, high-intensity interval training, PGC-1alpha, mitochondrial biogenesis, TCA flux, respiration, substrate use, or skeletal-muscle performance. Ten primary records were coded by organism, perturbation, endpoint class, timing, support lane, and claim boundary. Endpoint classes included skeletal muscle molecular, morphology, function, and clinical performance. No pooled estimate was calculated because the evidence mixed human biopsy time courses, mouse transporter or obesity models, and C2C12 exposure systems.
**Results:** Seven coded records supported a mitochondrial routing claim, one was mixed, and two were constraint records. Lactate/MCT evidence supported transporter-sensitive effects on mitochondrial proteins, TCA flux, respiration, fatty-acid oxidation, and multi-omics adaptation [1-3]. Human interval-training studies supported mitochondrial-biogenesis signaling and performance adaptation after acute or repeated exercise but did not isolate lactate as sufficient [4-6,10]. Pyruvate cell studies supported substrate-linked mitochondrial remodeling while warning that respiratory-chain content can dissociate from substrate use and PGC-1alpha directionality [8,9]. The clearest discriminating test is therefore not whether lactate rises after exercise, but whether matched transporter state and carbon-entry measurements separate molecular adaptation from performance sufficiency.
**Conclusions:** The public claim supported by the evidence is that lactate-pyruvate routing can participate in skeletal-muscle mitochondrial fuel signaling and adaptation. The evidence does not support lactate supplementation, pyruvate exposure, or a single transporter marker as a stand-alone performance intervention, disease treatment, or clinical prescription rule.
Download the manuscript PDF
DOI: 10.5281/zenodo.23376202